New test could save lives by spotting hidden cause of kidney failure
NCT ID NCT04745195
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 26 times
Summary
This study aims to improve diagnosis of thrombotic microangiopathy (TMA), a life-threatening condition where small blood clots damage organs like the kidneys and brain. Researchers will test a new blood test (HMEC test) in 42 adults to see if it can better identify which cases are caused by a specific immune system problem (complement defects). The goal is to help doctors choose the right treatment faster and move toward personalized medicine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOTIC MICROANGIOPATHIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maastricht University Medical Center
RECRUITINGMaastricht, Limburg, 6229HX, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.